Logo Join | Forum| Help | Bookmark | Login
Submit New Story
Home Stories Groups People Marketplace | FREE Benefits
Forum Home >> Health >> Cancer >> Breast >> FDA Approves Evista for Prevention of Breast Cancer
 
Search
Author Messages

RavenCares

Joined: 25-Jul-2007
Posts: 197
Posted: Mon Sep 17, 2007 04:21 am
Post topic: FDA Approves Evista for Prevention of Breast Cancer		  
On September 14, 2007, the U.S. Food and Drug Administration (FDA) approved the use of Evista, an osteoporosis drug, for postmenopausal women who want to prevent breast cancer. The director of the FDA's Center for Drug Evaluation and Research warns that Evista may not be appropriate for all postmenopausal women, however.

There are two groups of women who Evista may help: postmenopausal women who have osteoporosis, and postmenopausal women who are at high risk of contracting invasive breast cancer. With the new FDA approval, Evista becomes the second drug for preventing breast cancer, with Tamoxifen being the first.
Tags: breast-cancer , prevention , risk-reduction , Evista , Osteoporosis , FDA , Tamoxifen
 
Author Messages

Sissy

Joined: 18-Jul-2007
Posts: 248
Posted: Sat Jan 12, 2008 08:42 pm
Post topic: FDA Approves Evista for Prevention of Breast Cancer		  
I just did a little research on this med because they recommended my mother begin taking it. It is suppose to decrease the chance of cancer - sounds like a winner to me!

Sissy
 
 
 

UnitedProject.org Inc. (c) 2006-2008 All content published on UnitedProject.org is provided for informational purposes only and is not meant to substitute for the advice, diagnosis or treatment provided by your physician or other healthcare professionals. If you think you are experiencing a medical problem or an emergency please contact your physician, local emergency room or call 911. Healthcare benefits and discounts are not insurance and not intended as a substitute for health insurance. Except when other source is cited, all content posted by members is licensed under Creative Commons Public Domain License.



Site last updated 07/03/08 - loaded in 0.1690 seconds